← FDA DRUG APPROVALS

FDA ANDA · ANDA040842

HYDROXYZINE HYDROCHLORIDE

Sponsor: NORTHSTAR HLTHCARE

APPLICATION
ANDA040842
TYPE
ANDA
ORIGINAL APPROVAL
2008-03-31
LATEST ACTION
2014-06-03
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

HYDROXYZINE HYDROCHLORIDEPrescription
HYDROXYZINE HYDROCHLORIDE 25MG · TABLET · ORAL

Approval history

2014-06-03Labeling · Supplement 6 · standardAP
2014-04-30Labeling · Supplement 5 · standardAP
2013-01-17Labeling · Supplement 4 · standardAP
2011-12-08Labeling · Supplement 3AP
2008-03-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →